Anvisa determines suspension of irregular and fake medicines

By ETCO
29/07/2011

Source: Estadão - São Paulo / SP - HEALTH - 22/10/2010

BRASILIA - The National Health Surveillance Agency (Anvisa) published on Friday, 22, in the Federal Official Gazette, measures that establish the suspension of products in an irregular situation, valid for the whole country.

It is forbidden to manufacture, distribute, market and use all batches of Muconat 30 mg / 5ml syrup in plastic bottles, produced by the company Nativita Indústria e Comércio Ltda. These lots are at odds with the model approved by Anvisa and will be collected.

The agency also suspended the manufacture, distribution, trade and use of all cleaning products by Raro Indústria e Comércio Ltda. The company is not authorized to operate or registered with Anvisa.

The 948 batch of the anabolic Hemogenin will also be withdrawn from the market, with an expiration date of 12/12, as it has been subject to forgery. The measure also applies to lots 33099 of the anabolic Deca-Durabolin 25mg; 11873 of Deca-Durabolin 50mg; 233314 of Deca-Durabolin 50mg; and 12658, 18874, 18341 and 03985 of the anabolic Durateston, with date of manufacture in 06/2008 and valid until 06/2012, whose holder of the records is the company Schering-Plogh Indústria Farmacêutica Ltda.